Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002563
Status:
COMPLETED
Last Update Posted:
2013-04-10
First Post:
1999-11-01
Brief Title:
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkins Disease
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Study Overview
Official Title:
Health Status and Quality of Life in Patients With Early Stage Hodgkins Disease A Companion Study to SWOG-9133
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer
PURPOSE This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I or stage II Hodgkins disease who are receiving radiation therapy with or without chemotherapy
PURPOSE This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I or stage II Hodgkins disease who are receiving radiation therapy with or without chemotherapy
Detailed Description:
OBJECTIVES I Evaluate prospectively the health status and quality of life of patients with Stage IIIA Hodgkins disease randomized on protocol SWOG-9133 CLB-9391 to treatment with subtotal nodal irradiation with vs without 3 courses of doxorubicinvinblastine II Describe the short-term effects of these treatments on these patients and compare their impact on quality of life ie patient symptom status health status fatigue III Evaluate the intermediate and long-term effects of these treatments on these patients and compare their impact on quality-of-life outcomes over 5 years
OUTLINE Quality-of-Life Assessment Cancer Rehabilitation Evaluation System Short Form CARES-SF Symptom and Personal Information Questionnaire including Symptom Distress Scale MOS SF-36 Fatigue Scale MOS SF-36 Health Perception Rating Demographics Cover Sheet
PROJECTED ACCRUAL Approximately 500 patients will be accrued over 7 years
OUTLINE Quality-of-Life Assessment Cancer Rehabilitation Evaluation System Short Form CARES-SF Symptom and Personal Information Questionnaire including Symptom Distress Scale MOS SF-36 Fatigue Scale MOS SF-36 Health Perception Rating Demographics Cover Sheet
PROJECTED ACCRUAL Approximately 500 patients will be accrued over 7 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CLB-9497 | OTHER | CALGB | httpsreporternihgovquickSearchU10CA032102 |
| U10CA032102 | NIH | None | None |
| SWOG-9208 | OTHER | None | None |